Tideglusib: Phase II started
AMO began a single-blind, placebo-controlled, U.K. Phase II trial to evaluate
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
AMO began a single-blind, placebo-controlled, U.K. Phase II trial to evaluate